Therefore, inactivating SRA1 mutations in our patients in this study must have caused hypogonadotropic hypogonadism by a mechanism other than via a decreased ER-alfa coactivation either at the hypothalamic or the pituitary level. This evidence concerns the gene SRA1 and hypogonadotropic hypogonadism.